Use

This panel provides combined assessment of metabolic and cardiovascular risk by measuring glucose, hemoglobin A1c, standard lipid components, and calculated risk scores—including an 8‑year diabetes risk and both 10‑year and lifetime ASCVD risk—enabling earlier identification of patients at elevated risk for type 2 diabetes mellitus and atherosclerotic cardiovascular disease, thereby supporting timely lifestyle or pharmacologic intervention ([questdiagnostics.com](https://www.questdiagnostics.com/healthcare-professionals/about-our-tests/cardiovascular/metabolic-testing/portfolio?utm_source=openai)).

Not provided.